Early-warning Intervention for Heat Waves and Cold Spells in Older Hypertensive Patients
Study Details
Study Description
Brief Summary
This study was designed to explore the impact of health-risk early-warning interventions for heat waves and cold spells on older hypertensive patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
From June 15th 2023 to August 31st 2023, and December 1st 2023 to February 28th 2024, researchers will conduct a double-blind, cluster randomised controlled trial involving 258 hypertensive patients aged 60 to 65 years in Wuqing District, Tianjin. For the sampling stage, three communities will be randomly selected in Wuqing District. The geographical distribution, urbanisation, population size, population structure, economic status, and health service resources of each selected community are in equilibrium. Meanwhile, the distance between the selected communities is greater than 5 km. Based on the list of chronic disease management records, 86 older hypertensive patients (male: female = 1:1) in each community will be involved in the intervention group, monitoring group, and blank control group, respectively. Eligible individuals for this trial will be a mean untreated systolic blood pressure of at least 140 mmHg or a mean untreated diastolic blood pressure of at least 90 mmHg, or a mean treated systolic blood pressure of at least 130 mmHg or a mean treated diastolic blood pressure of at least 80 mmHg. Patients with a history of coronary heart disease, heart failure, stroke or diabetes were exclueded. For the intervention stage, different groups have different intervention modalities including heat waves or cold spells warnings, monitoring of health indicators, questionnaire surveys, health checkups and biological sample collection. According to the heat waves or cold spells health warning systems conducted by National Institute of Environmental Health in the Chinese Center for Disease Control and Prevention, whenever a health risk warning for a heat waves or cold spells is issued, only the elderly in the intervention group will be alerted to the early warning information through the Wechat Mini Programme. The exposure temperature, electrocardiography (ECG), and blood pressure indicators will be monitored every day during the study period in the intervention group and monitoring group, respectively. The blank control group will only monitor the exposure temperature every day. Besides, the study period will be divided into two parts including pre-intervention and intervention periods, respectively, and all the patients will have questionnaire surveys, health checkups and biological sample collections once in the pre-intervention period and three times in the intervention period. Biological biomarkers of inflammation and oxidative stress in the cardiovascular system will be tested. The content of the questionnaire will include individual fundamental information, the perception of the health risk of heat waves and cold spells, sleep quality, hypertension medication.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Early-warning interventions The elderly in the intervention group will receive warning messages through WeChat mini programs and monitor daily exposure temperature, electrocardiogram (ECG), and blood pressure indicators |
Behavioral: Information notification based on the health warning system for heat waves and cold spells
Whenever a health risk warning for a heat waves or cold spells is issued, only the elderly in the intervention group will be alerted to the early warning information through the Wechat Mini Programme.
Device: The electrocardiography(ECG) and blood pressure monitoring
The electrocardiography (ECG) and blood pressure indicators will be monitored every day during the study period in the intervention group and monitoring group, respectively.
|
| Other: Health monitoring The exposure temperature, electrocardiography (ECG), and blood pressure indicators will be monitored every day during the study period in the monitoring group |
Device: The electrocardiography(ECG) and blood pressure monitoring
The electrocardiography (ECG) and blood pressure indicators will be monitored every day during the study period in the intervention group and monitoring group, respectively.
|
| No Intervention: Blank control The blank control group will only monitor the exposure temperature every day. |
Outcome Measures
Primary Outcome Measures
- Observation indicators:Individual fundamental information [six months]
Weight and height will be combined to report BMI in kilogram/meter^2 (kg/m^2).
- Observation indicators:Sleep quality [six months]
Sleep duration in hour.
- Functional indicators:Blood pressure [six months]
Diastolic pressure and systolic pressure in millimetre of mercury (mmHg).
- Functional indicators:Monitoring indicators of electrocardiogram-1 [six months]
AverageHeartRate in beat per minute(bpm),MaxHeartRate in bpm,MinHeartRate in bpm.
- Functional indicators:Monitoring indicators of electrocardiogram-2 [six months]
ECG QT interval inMillisecond(ms),PR interval in ms.
- Functional indicators:Monitoring indicators of electrocardiogram-3 [six months]
QRS Electrical axis in degree.
Secondary Outcome Measures
- Experimental test index:Biomarkers of inflammation in the cardiovascular system-1 [six months]
Cardiac troponin in microgram/litre(μg/L),Heart fatty acid binding protein in μg/L.
- Experimental test index:Biomarkers of inflammation in the cardiovascular system-2 [six months]
C-reactiveprotein in milligram/litre(mg/L),D-dimer in mg/L.
- Experimental test index:Biomarkers of inflammation in the cardiovascular system-3 [six months]
Creatine kinase isoenzyme-MB in unit/liter(U/L).
- Experimental test index:Biomarkers of inflammation in the cardiovascular system-4 [six months]
NT-proBNP in picogram/milliLiter(pg/ml),Interleukin-6 in pg/ml.
- Experimental test index:Biomarkers of inflammation in the cardiovascular system-5 [six months]
Myoglobin in nanogram/milliliter(ng/mL).
- Experimental test index:Biomarkers of inflammation in the cardiovascular system-6 [six months]
B-type natriuretic peptides in picogram/Litre(pg/L).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
60 ≤ 65 years old
-
Volunteer to participate in this study
Exclusion Criteria:
-
Patients with a history of coronary heart disease, heart failure, stroke or diabetes were exclueded.
-
Unable to cooperate with follow-up
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | National Institute of Environmental Health, Chinese Center for Disease Control and Prevention | Beijing | China | 100021 |
Sponsors and Collaborators
- Tiantian Li
Investigators
- Study Director: Tiantian Li, National lnstitute of Environmental Health, Chinese Center for Disease Controland Prevention
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 202361